EGFR and head and neck squamous cell carcinoma: Cetuximab resistance may also arise in HNSCC through alternative mechanisms, including via activation of other signaling pathways, such as the G-protein-coupled receptor (GPCR)-mediated autocrine release of EGFR ligands [4,5,6].